CICLUM FARMA UNIPESSOAL LDA secures contract for Acquisition Of Ustecinumab 45 Mg Sol Inj Biosimilar Singinga

Portugal, Aug. 22 -- Portugal based CICLUM FARMA UNIPESSOAL LDA has secured contract from Unidade Local De Saude De Santa Maria, E. P. E. for Acquisition Of Ustecinumab 45 Mg Sol Inj Biosimilar Singinga. The value of the contract is worth 9280000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....